COVID-19 vaccine deliberation among people who inject drugs.
COVID-19 vaccine deliberation among people who inject drugs.
复制标题
DOI:
10.1016/j.dadr.2022.100046
复制
发表时间:
2022-06
期刊:
影响因子:
--
通讯作者:
Tavalire HF
中科院分区:
文献类型:
--
作者:
Cioffi CC;Kosty D;Nachbar S;Capron CG;Mauricio AM;Tavalire HF
Uptake was low during COVID-19 vaccine roll out among people who inject drugs. More than 40% of those who were unvaccinated desired to be vaccinated. This highlights disparities in vaccine access for PWID. Compared to the general population, reasons for vaccination were similar for PWID. People who inject drugs (PWID) are at greater risk for severe morbidity and mortality associated with COVID-19 due to comorbid, chronic, medical conditions and structural inequities associated with housing instability and incarceration. As such, they are a population that would greatly benefit from COVID-19 vaccination. We surveyed 350 syringe exchange clients between March 2021 and June 2021 to collect information on vaccine uptake among PWID, facilitators and barriers to vaccination, and demographic correlates of vaccine hesitancy. Findings highlight that among PWID, vaccination access was remarkably low with only 10% of the sample receiving a COVID-19 vaccine. Vaccine acceptability among people who were unvaccinated was 42% highlighting barriers to access. Motivation for vaccination included a desire to keep family members and other community members safe and a desire to feel safe around other people. Barriers to vaccination included concerns about vaccine side effects, lack of concern surrounding the effects of COVID-19, and insufficient information about how the vaccine works, along with general distrust of the vaccine development and deployment process. There is a need for structural interventions and individual behavioral interventions to improve COVID-19 vaccine access and uptake among PWID. Limitations and implications for next steps and future directions are discussed.
登录
查看更多内容
影响因子:
4.2
作者:
Masson CL;McCuistian C;Straus E;Elahi S;Chen M;Gruber VA;Le T;Guydish J
通讯作者:
Guydish J
影响因子:
5.9
作者:
Khubchandani J;Sharma S;Price JH;Wiblishauser MJ;Sharma M;Webb FJ
通讯作者:
Webb FJ
影响因子:
6.2
作者:
Rodriguez RM;Torres JR;Chang AM;Haggins AN;Eucker SA;O'Laughlin KN;Anderson E;Miller DG;Wilkerson RG;Caldwell M;Lim SC;Raja AS;Baumann BM;Graterol J;Eswaran V;Chinnock B;REVVED UP Investigators
通讯作者:
REVVED UP Investigators
影响因子:
4.2
作者:
Campbell, Jennifer V.;Garfein, Richard S.;Weinbaum, Cindy
通讯作者:
Weinbaum, Cindy
影响因子:
3.5
作者:
Wake AD
通讯作者:
Wake AD